niacinamide has been researched along with Tuberous Sclerosis in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, J | 1 |
| Samsel, PA | 1 |
| Narov, K | 1 |
| Jones, A | 1 |
| Gallacher, D | 1 |
| Gallacher, J | 1 |
| Sampson, JR | 1 |
| Shen, MH | 1 |
| Lee, N | 1 |
| Woodrum, CL | 1 |
| Nobil, AM | 1 |
| Rauktys, AE | 1 |
| Messina, MP | 1 |
| Dabora, SL | 1 |
| Cohen, JD | 1 |
| Tham, KY | 1 |
| Mastrandrea, NJ | 1 |
| Gallegos, AC | 1 |
| Monks, TJ | 1 |
| Lau, SS | 1 |
| Singer, EA | 1 |
| Gupta, GN | 1 |
| Srinivasan, R | 1 |
1 review available for niacinamide and Tuberous Sclerosis
| Article | Year |
|---|---|
Targeted therapeutic strategies for the management of renal cell carcinoma.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Clinical Trials as Topic; Disease-F | 2012 |
3 other studies available for niacinamide and Tuberous Sclerosis
| Article | Year |
|---|---|
Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2
Topics: Animals; ATP-Binding Cassette Transporters; Cell Death; Cell Line, Tumor; Disease Models, Animal; Dr | 2017 |
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
Topics: Animals; Atorvastatin; Benzenesulfonates; Cystadenoma; Disease Models, Animal; Doxycycline; Drug Eva | 2009 |
cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Topics: Animals; Benzenesulfonates; Bucladesine; Carcinoma, Renal Cell; Cell Line; Cyclin D1; Cyclin-Depende | 2011 |